LONG-TERM SAFETY AND TOLERABILITY OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: A PHASE 3, RANDOMIZED, CONTROLLED TRIAL

Authors
Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2014
This article has no abstract
Epistemonikos ID: dc6a5501d61004b7bcd30d526ec36fb27bc472df
First added on: May 19, 2017